Carl Icahn Exits Dana And Illumina: Capital Redeployment Signals Portfolio Repositioning

Carl Icahn’s latest 13F filing reveals a decisive shift in his portfolio strategy. The legendary activist investor exited two positions entirely this quarter: Dana Inc. (DAN) and Illumina Inc. (ILMN).

A Clean Break From Industrials And Biotech

The moves were not small trims but full disposals—100% exits that remove both names from Icahn’s holdings.

• Dana Inc. (DAN): Icahn unloaded his 14.3 million shares, previously worth $190.4 million and representing 2.54% of his total portfolio. Dana, a long-standing holding in the industrials space, has faced cyclical headwinds from both supply chain volatility and uneven demand across the automotive sector.
• Illumina Inc. (ILMN): The biotech giant was a much smaller position—just 220,000 shares worth $17.45 million last quarter. Still, its full removal suggests Icahn sees limited near-term catalysts in a company once central to debates over genomic sequencing economics and activist governance battles.

Reading Between The Lines

Icahn’s style has always leaned toward concentrated, high-conviction bets. Selling out of two very different sectors in the same quarter hints at a desire to redeploy capital toward more promising opportunities—whether in existing holdings or entirely new targets.

Historically, Icahn has not hesitated to exit long-held positions when the risk/reward profile shifts unfavorably. The exits could free up nearly $208 million for future activism or opportunistic buys at a time when market volatility continues to create entry points for deep-value investors.

What Comes Next?

For now, the exits leave Icahn’s portfolio even more concentrated in energy, industrial conglomerates, and consumer names. Investors following his moves closely will be watching the next 13F for signs of where that liberated capital lands.